Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2012
09/05/2012CN101756955B Chinonin complex, preparation method and application thereof
09/05/2012CN101745042B Composition with effects of relieving alcoholism and protecting liver and preparation method thereof
09/05/2012CN101732466B Method for controlling quality of Guipi granules
09/05/2012CN101732317B Analgetic composition and application thereof
09/05/2012CN101721442B Method for preparing ginseng soaked by rice vinegar
09/05/2012CN101709292B Recombinant adenovirus, and preparation method and application thereof
09/05/2012CN101686977B Therapeutic or prophylactic agent for dyskinesia
09/05/2012CN101679457B Piperazine and [1,4] diazepan derivatives as NK antagonists
09/05/2012CN101658601B Chinese medicinal preparation for treatment or adjuvant treatment of Parkinson's diseases
09/05/2012CN101638423B Phloridzin derivative as well as preparation method and application thereof
09/05/2012CN101611013B Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
09/05/2012CN101415418B Agent exhibiting a neuromodulator activity
09/05/2012CN101380388B Traditional Chinese medicine preparation for treating vascular headache
09/05/2012CN101362748B Method for preparing sertindole
09/05/2012CN101336106B Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
09/04/2012US8258305 Dopamine transporter inhibitors for use in treatment of movement disorders and other CNS indications
09/04/2012US8258295 Triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives
09/04/2012US8258288 RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)
09/04/2012US8258262 N-terminally chemically modified protein compositions and methods
09/04/2012US8258185 Use of neboglamine in the treatment of toxicodependency
09/04/2012US8258174 Method of inhibiting apoptosis
09/04/2012US8258172 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
09/04/2012US8258135 Quinolizidinone M1 receptor positive allosteric modulators
09/04/2012US8258133 2-amino-bicyclo[3.1.0]hexane-2, 6-dicarboxylic ester derivative
09/04/2012US8258132 Pharmaceutical composition of a tachykinin receptor antagonist
09/04/2012US8258122 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
09/04/2012US8257745 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
09/04/2012US8257741 Solid pharmaceutical dispersions with enhanced bioavailability
09/04/2012CA2507429C Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
09/04/2012CA2471812C Targeted retrograde gene delivery to motor neurons
08/2012
08/30/2012WO2012116176A2 Asymmetric ureas and medical uses thereof
08/30/2012WO2012116128A1 Use of teriflunomide for treating cognitive impairment
08/30/2012WO2012115608A2 Polyamine inhibitors for the treatment and prevention of parkinson's disease
08/30/2012WO2012115446A2 Compound based on 5-(substituted alkyl-aminomethyl) isoxazole acting as a t-type calcium channel antagonist
08/30/2012WO2012115439A2 Composition comprising expression or activity regulators of akap12 for treating central nerve system diseases
08/30/2012WO2012115241A1 Fcγriib-specific fc antibody
08/30/2012WO2012115185A1 Composition for treatment, amelioration or prophylaxis of pain
08/30/2012WO2012115097A1 Glycine transport inhibitor
08/30/2012WO2012115066A1 Glycine transport inhibitor
08/30/2012WO2012114926A1 Thioamide compound, method for producing thioamide compound, method for producing [(4r,6r)-6-aminoethyl-1,3-dioxane-4-yl]acetate derivative, and method for producing atorvastatin
08/30/2012WO2012114348A1 Novel compounds as histamine h3 receptor ligands
08/30/2012WO2012114285A1 Heteroaryl derivatives as alpha7 nachr modulators
08/30/2012WO2012114268A1 Benzamide derivatives as p2x7 receptor antagonists
08/30/2012WO2012114252A1 Novel indole and pyrrolopyridine amides
08/30/2012WO2012114222A1 IMIDAZO[5,1-f][1,2,4]TRIAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
08/30/2012WO2012113850A2 (PYRIDIN-4-YL)BENZYLAMIDES AS ALLOSTERIC MODULATORS OF ALPHA 7 nAChR
08/30/2012WO2012113775A1 Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders
08/30/2012WO2012113103A1 Asymmetric ureas and medical uses thereof
08/30/2012WO2012113079A1 Cystamine analogues for the treatment of parkinson's disease
08/30/2012WO2012094081A3 System and method for identifying and applying peripheral treatment mechanisms for disease
08/30/2012WO2012089811A3 Transdermal application system comprising a protruding backing film
08/30/2012WO2012046250A3 Polymorphic forms of o-desmethyl-venlafaxine succinate field of the invention
08/30/2012WO2012016707A3 Oral dosage form for the modified release of dimebolin
08/30/2012US20120220922 Photolabile compounds
08/30/2012US20120220666 Composition to enhance the bioavailability of curcumin
08/30/2012US20120220660 Composition With Preventive or Improvement Effect on Symptoms or Diseases Associated with Stress-Induced Behavior Disorders
08/30/2012US20120220657 Synergistic anti-inflammatory and antioxidant dietary supplement compositions
08/30/2012US20120220635 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
08/30/2012US20120220629 Asymmetric ureas and medical uses thereof
08/30/2012US20120220627 Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators
08/30/2012US20120220624 Pyrazolo [3,4-b] pyridin-4-one kinase inhibitors
08/30/2012US20120220622 Heterocyclic derivatives
08/30/2012US20120220605 Oxopiperazine derivatives for the treatment of pain and epilepsy
08/30/2012US20120220604 Piperazinyl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/30/2012US20120220603 Substituted heterocyclic derivatives for the treatment of pain and epilepsy
08/30/2012US20120220599 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
08/30/2012US20120220598 Besylate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4 Methyl-1-Piperazinyl)Carbonyloxy]-7-oxo-6, 7-dihydro-5H-Pyrrolo[3,4-b]Pyrazine
08/30/2012US20120220597 L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine
08/30/2012US20120220596 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
08/30/2012US20120220592 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
08/30/2012US20120220591 Pyrimidone compounds
08/30/2012US20120220587 Pyridinylimidazolone derivatives for the inhibition of pi3 kinases
08/30/2012US20120220586 Heterocyclic compounds and their uses
08/30/2012US20120220585 Heterocyclic compounds and their uses
08/30/2012US20120220583 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
08/30/2012US20120220582 Imidazopyrazine syk inhibitors
08/30/2012US20120220581 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
08/30/2012US20120220579 Methods of utilizing arylpiperazine derivatives
08/30/2012US20120220577 Glycine b antagonists
08/30/2012US20120220576 Novel Heterocyclic Derivatives
08/30/2012US20120220575 N-substituted oxazinopteridines and oxazinopteridinones
08/30/2012US20120220574 Methods of utilizing arylpiperazine derivatives
08/30/2012US20120220568 Histamine-3 Receptor Antagonists
08/30/2012US20120220564 Selective calcium channel modulators
08/30/2012US20120220559 Controlled Release and Taste Masking Oral Pharmaceutical Composition
08/30/2012US20120220556 Drospirenone for hormone replacement therapy
08/30/2012US20120220552 (thio)morpholine derivatives as s1p modulators
08/30/2012US20120220544 Ganglioside Transmucosal Formulations
08/30/2012US20120220539 Conotoxin peptides
08/30/2012US20120220535 Cyclic-glur6 analogs, methods of treatment and use
08/30/2012US20120220534 Biomarker for neurodegeneration in neurological disease
08/30/2012US20120220533 Modulating neuromuscular junction density changes in botulinum-toxin treated tissue
08/30/2012US20120219970 Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
08/30/2012US20120219649 Process for the preparation of herbal extract of cassia tora leaves for treating anxiety disorders
08/30/2012US20120219645 Chinese Herbal Aqueous Extract Having Anti-Anxiety Activities and Method of In Vitro Evaluating the Same
08/30/2012US20120219641 5-ht3 receptor modulators, methods of making, and use thereof
08/30/2012US20120219631 Modified release formulation of lacosamide
08/30/2012US20120219623 Pharmaceutical compositions comprising bi-1356 and metformin
08/30/2012US20120219616 LIPOSOMAL REDUCED GLUTATHIONE AND l-ARGININE, INCLUDING WITH OTHER INGREDIENT(S), CAPABLE OF MULTIPATH ADMINISTRATION FOR REVERSAL AND PREVENTION OF OBESITY AND FOR MITOCHONDRIAL BIOGENESIS
08/30/2012US20120219614 Methods and compositions for preventing a condition
1 ... 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 ... 1833